Cargando…
From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the le...
Autores principales: | Sharfstein, Joshua M., Conti, Rena M., Gee, Rebekah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341206/ https://www.ncbi.nlm.nih.gov/pubmed/35902083 http://dx.doi.org/10.1017/jme.2022.32 |
Ejemplares similares
-
Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic
por: Killelea, Amy, et al.
Publicado: (2022) -
PH WINS and the Future of Public Health Education
por: Resnick, Beth A., et al.
Publicado: (2019) -
Ensuring adequate health financing to prevent and control the COVID-19 in Iran
por: Behzadifar, Masoud, et al.
Publicado: (2020) -
Public health and the legal regulation of the pharmaceutical industry in Algeria
por: Alsamara, Tareck, et al.
Publicado: (2022) -
Vaccine financing in Nigeria: are we making progress towards self-financing/sustenance?
por: Faniyan, Olumide, et al.
Publicado: (2017)